| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 221 | 二日酔い予防又は治療用組成物 | JP2014086144 | 2014-04-18 | JP2014210773A | 2014-11-13 | PAEK SE HEE; MOON BYOUNG SEOK; PARK SEOK JUN; SEO YONG KI; SONG GEUN SEOG |
| 【課題】ゲッケイジュ葉抽出物を含む二日酔い予防又は治療用組成物、食品組成物、及び前記組成物の製造方法の提供。【解決手段】ゲッケイジュ葉をアルコール等で抽出した抽出物を含む、著しく優れた血中アルコール濃度及びアセトアルデヒド濃度減少効果を有する、その効果が行動学的にも確認された、二日酔い予防及び治療に効果的に用いることのできる食品、医薬又は健康機能食品。更にオオガタホウケン抽出物、イザヨイバラ抽出物を含む二日酔い予防又は治療用組成物【選択図】なし | ||||||
| 222 | Composition for the treatment of connective tissue | JP2009540264 | 2007-12-05 | JP5606071B2 | 2014-10-15 | トッド アール． ヘンダーソン; カルメリータ フロンドーザ |
| 223 | Autism of the therapeutic agent | JP2014512006 | 2011-05-26 | JP2014516047A | 2014-07-07 | 美智士 谷 |
| 【課題】免疫学的因子の抑制により副作用が少ない自閉症に適した改善薬を提供する。
【解決手段】セロリシード、小麦、レモンバーム、ミント、フェヌグリークシード、ステビア、月桂樹、黒糖末およびローズマリーを含有し、自閉症に対する症状を改善する作用を有することを特徴とする自閉症改善剤とする。 【選択図】図２ |
||||||
| 224 | Pharmaceutical compositions and their preparation for the treatment of bronchitis | JP2012517995 | 2009-06-30 | JP5502197B2 | 2014-05-28 | イーリン ウー; ヨンフェン チャン; ホンフイ シュー; シャオヤン リ; シュエリ ジ; シャオリ ウー; チャオ ワン; ユンペン リ; メン ワン |
| 225 | Java Nikkei of the extract, the extraction method, as well as proton pump down regulator, the use of it as enzyme inhibitors and mucosal protective agent | JP2013557214 | 2012-03-09 | JP2014508774A | 2014-04-10 | アリフィン，ポッピー・フィルザニ; エル．ウェー．，ディージー・ディア・ドウィ; ユリアニ，ヴェロニカ; シナンベラ，ジェームズ・エム; チャンドラウィナタ，レイモンド・エル |
| ジャワニッケイ(Cinnamomum burmanii)からの抽出物および／または画分（ＤＬＢＳ２４１１）は、それの抽出方法およびそれの生物活性に関連して、粘膜保護を付与しかつＨ
＋ ／Ｋ
＋ ＡＴＰａｓｅをダウンレギュレートすることにより、抗潰瘍剤としての活性を示す。 ＤＬＢＳ２４１１による処置は、ＨＥＫ ２９３細胞および胃壁細胞においてＨ
＋ ／Ｋ
＋ ＡＴＰａｓｅ ｍＲＮＡレベルを低下させる。 さらに、ＤＬＢＳ２４１１は胃の酵素Ｈ
＋ ／Ｋ
＋ ＡＴＰａｓｅの活性を阻害し、その際、ｐＨがこの阻害機序に影響を及ぼす。 ＤＬＢＳ２４１１は抗酸化剤としての特徴も備え、これは投与量の増加に伴う還元力増大により示される。
【選択図】 図１ |
||||||
| 226 | Hangover composition comprising a consideration 雙和 hot water, including the fear as an active ingredient | JP2010535873 | 2008-11-24 | JP5340302B2 | 2013-11-13 | ユル マ，ジン |
| A composition for alleviation of alcohol induced hangover comprises Ssangwhatang including Hoveniae Semen or lactobacillus fermented Ssangwhatang as an effective ingredient. Specifically, the composition comprises Ssangwhatang including Hoveniae Semen extracts or lactobacillus fermented Ssangwhatang prepared by inoculating, culturing and fermenting or lactobacillus. The composition is useful in alleviation of alcohol induced hangover and reducing blood-alcohol concentration during alcohol intake when taken as a health food. | ||||||
| 227 | Obesity or hypoglycemic composition containing a Hariguwa and coix, as well as its applications | JP2013528130 | 2011-09-09 | JP2013537890A | 2013-10-07 | グ キム，ヒョン; リョン ド，ジョン; ハン，チャン−ギュ |
| The present invention relates to a pharmaceutical composition for suppressing obesity or lowering blood sugar which comprises Cudrania tricuspidata extract and Coix lachryma-jobi extract, and more specifically relates to a pharmaceutical composition for suppressing obesity or lowering blood sugar which comprises Cudrania tricuspidata extract and Coix lachrymajobi extract, to a functional health food or food additive composition for suppressing obesity or lowering blood sugar which comprises Cudrania tricuspidata extract and Coix lachryma-jobi extract, to a tablet having an obesity-suppressing function and blood-sugar lowering effect which is produced using Cudrania tricuspidata and Coix lachryma-jobi as principal raw materials, and to a production method therefor. | ||||||
| 228 | Stabilizing agents of lymphatic | JP2012031106 | 2012-02-15 | JP5221783B2 | 2013-06-26 | 健太朗 加治屋; 正弘 大田 |
| 229 | Jijifusu-Joazeiro methods related oral composition and containing an extract of | JP2012542140 | 2010-12-01 | JP2013512909A | 2013-04-18 | トリヴェディ，ハーシュ・エム; ギティンス，エリザベス・ケイ |
| 本明細書において、抽出物の組み合わせを含む組成物、ならびにその同じものを調製する、および用いる方法を記述する。
【選択図】なし |
||||||
| 230 | Chinese medicine jelly pharmaceutical composition | JP2002220191 | 2002-07-29 | JP5153045B2 | 2013-02-27 | 常浩 福地; 耕司 松浦; 昇 辰巳; 真健 大楽; 美津雄 富樫 |
| 231 | Malignant tumor therapeutic agent derived from plants | JP2008504981 | 2007-02-15 | JP5131855B2 | 2013-01-30 | 孝 鈴木; 康雄 藤本; 武人 内山; 恵市 田畑 |
| 232 | Used for the treatment and prevention of diseases associated with immune system deficiency, drug comprising a peptide extract of avocado | JP2007510082 | 2005-04-29 | JP4995078B2 | 2012-08-08 | アントワーヌ、ピッチリリ; ステファニー、ブレディフ; ナタリー、ピカルディ; フィリップ、ムシカ; フランソワ、ポール |
| 233 | Stabilizing agents of lymphatic | JP2010517947 | 2009-06-17 | JP4970594B2 | 2012-07-11 | 健太朗 加治屋; 正弘 大田 |
| 234 | Lymphatic vessel stabilizer | JP2012031106 | 2012-02-15 | JP2012107041A | 2012-06-07 | KAJIYA KENTARO; OTA MASAHIRO |
| PROBLEM TO BE SOLVED: To provide a lymphatic vessel stabilizer composed of a Tie2 activator.SOLUTION: The Tie2 activator is preferably at least one selected from the group consisting of angiopoietin 1 (Ang-1), extract of Cinnamomum species plants, extract of Siberian Ginseng, and syringaresinol. | ||||||
| 235 | Cellular life span extending agent, and telomerase activator | JP2010232664 | 2010-10-15 | JP2012087068A | 2012-05-10 | KAJIYA KENTARO; TAKAKURA NOBUYUKI |
| PROBLEM TO BE SOLVED: To provide a new cellular life extending agent, especially a vascular endothelial cellular life span extending agent, and a telomerase activator.SOLUTION: The new cellular life span extending agent, particularly an agent for extending the life span of an endothelial cell, and the telomerase activator, each comprising an extract derived from a plant belonging to the genus Cinnamomum, Lauraceae family, i.e., cinnamon bark or cassia, are provided. These agents are each a pharmaceutical effective for preventing and ameliorating various diseases caused by cellular aging and aging, namely, various inflammatory diseases, immunological diseases, lifestyle-related diseases, etc., for example, various infectious diseases, articular rheumatism, gout, hypertension, diabetes, arteriosclerosis, hyperlipemia, obesity, organ dysfunction, etc. | ||||||
| 236 | リンパ管の安定化剤 | JP2010517947 | 2009-06-17 | JPWO2009154237A1 | 2011-12-01 | 健太朗 加治屋; 大田 正弘; 正弘 大田 |
| Tie2活性化剤からなる、リンパ管の安定化剤を提供する。Tie2活性化剤は、好ましくはアンジオポエチン1(Ang-1)、ニッケイ(Cinnamomum)属植物の抽出物、シベリアニンジン(Siberian Ginseng)抽出物及びシリンガレシノールからなる群から選択される少なくとも1種である。 | ||||||
| 237 | Cartilage regeneration, of pain suppression and edema suppression for herbal composition | JP2011516125 | 2009-06-24 | JP2011525527A | 2011-09-22 | ヘクァン オァ; ソンヒ キム; ソンヨン キム; ジンヨン チェ; ビンウク チョウ; スジン パク |
| The present invention relates to a pharmaceutical composition for cartilage regeneration, pain suppression, and edema suppression, and more particularly, to a drug composition, comprising herbal extracts of Chaenomelis Fructus, Achyranthis Radix, Acanthopanax, Cinnamomi Cortex, Gentianae Radix, Clematidis Radix, Angelicae Radix, Cnidii Rhizoma, Gastrodiae Rhizoma, Safflower, Rhlomidis Radix, and Ledebouriellae Radix as active ingredients, which has no significant adverse side effects, suppresses pain and edema, and is effective in cartilage regeneration, thus is applicable in medicines, health foods, food additive or feed additives. | ||||||
| 238 | Useful formulation to impotence treatment of men and women | JP2004503027 | 2003-05-02 | JP4733385B2 | 2011-07-27 | セギッツィ，ロベルト; ボンバルデッリ，エツィオ; モラツォーニ，パオロ; リーバ，アントネラ |
| 239 | Formulation of a mixture of free -b- ring flavonoids and flavans as a therapeutic agent | JP2004500784 | 2003-04-30 | JP4723239B2 | 2011-07-13 | ジア，キ |
| The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds --Free-B-ring flavonoids and flavans-- for use in the prevention and treatment of diseases and conditions mediated by the COX-2 and 5-LO pathways. The present invention further provides a novel method for simultaneously inhibiting the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) enzymes, and reducing cox-2 mRNA production. Finally, the present invention includes a method for weight loss and blood glucose control. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier.; This invention relates generally to the prevention and treatment of diseases and conditions mediated by the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) pathways, including but not limited to the relief joint discomfort and pain associated with conditions such as osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse. | ||||||
| 240 | Compositions and methods for promoting and maintaining the production of neurotransmitters | JP2004532915 | 2003-08-18 | JP4719832B2 | 2011-07-06 | ウィリアム イー． シェル，; エリザベス エイチ． チャルバストラ， |
QQ群二维码
意见反馈
意见反馈